RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

Presentations

Date

Title

Video

Transcript

Presentation

01/19/2021

Noble Capital Markets Annual Presentation

10/29/20

Investor Summit Presentation

Latest Press Releases

RenovaCare Responds to SEC Complaint

Roseland, NJ – June 1st, 2021 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced that it intends to vigorously defend itself and its stockholders against allegations made by the U.S. Securities and Exchange Commission (“SEC”) in a civil complaint filed on May 28, 2021 regarding legacy events (the “Complaint”) from over 3 years ago.

Read more

Company Overview

RenovaCare, Inc. is committed to the highest standards of ethical behavior and the Company’s commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

Corporate Office:

RenovaCare, Inc.
4 Becker Farm Road, Suite 105
Roseland, New Jersey 07068
1-888-398-0202

Sign Up for Investor Alerts